Iris Acquisition Corp
Status: Closed Deal
U=S+W/4
W=S@11.5
| IPO Proceeds, $M | $276.00M |
|---|---|
| IPO Date | Mar 5, 2021 |
| CEO | Sumit Mehta |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 6 + 6 + 6 + 3 + 3 |
| IPO Sector | General ▶ |
| IPO Geography | Global |
| Target Company | Liminatus Pharma |
| Deal Announced | Nov 30, 2022 |
| Deal Size, $M | $175.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Mar 4, 2025 |
| Amendment Vote | Dec 20, 2024 |
| Closing Date | Apr 30, 2025 |
Formerly IRAA
LIMN
LIMNW
| Price | $7.01 |
|---|---|
| Last closing price | $5.22 |
| H/L, today | $5.82 / $7.45 |
| Volume, today | 822,339 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.